TRCLF(TRCLF)
TRCLF
No analyst ratings available
No analyst price targets available for TRCLF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $420.15B | $440.79B | $462.32B | $477.30B |
| Low | $417.30B | $435.62B | $458.02B | $472.86B |
| High | $423.00B | $445.95B | $466.63B | $481.74B |
| EBITDA Avg | $25.67B | $26.95B | $28.43B | $28.26B |
| Low | $25.43B | $26.70B | $28.16B | $27.99B |
| High | $25.91B | $27.21B | $28.70B | $28.53B |
| EBIT Avg | $20.04B | $21.32B | $22.74B | $22.49B |
| Low | $19.80B | $21.06B | $22.46B | $22.21B |
| High | $20.29B | $21.58B | $23.01B | $22.76B |
| Net Income Avg | $13.61B | $14.48B | $15.44B | $15.27B |
| Low | $13.44B | $14.30B | $15.26B | $15.09B |
| High | $13.77B | $14.65B | $15.63B | $15.46B |
| EPS Avg | $340.62 | $362.41 | $386.60 | $382.29 |
| Low | $336.50 | $358.02 | $381.93 | $377.67 |
| High | $344.74 | $366.79 | $391.28 | $386.92 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $106.01B | $106.91B | $107.64B |
| Low | $106.01B | $106.91B | $107.64B |
| High | $106.01B | $106.91B | $107.64B |
| EBITDA Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EBIT Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Net Income Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EPS Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — | 1 / — |